Cargando…

A Comparison of the Toxicities in Patients With Locally Advanced Head and Neck Cancers Treated With Concomitant Boost Radiotherapy Versus Conventional Chemoradiation

Purpose: To compare the objective and patient-reported toxicities of concomitant boost radiotherapy (CBRT) and concurrent chemoradiation (CRT) in patients with locally advanced head and neck cancers. Methods and material: In this prospective study, 46 patients with histologically proven stage III-IV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharma, Ritu, Vats, Siddharth, Seam, Rajeev, Gupta, Manish, Negi, Ratti R, Fotedar, Vikas, Singh, Kaalindi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230179/ https://www.ncbi.nlm.nih.gov/pubmed/37266055 http://dx.doi.org/10.7759/cureus.38362

Ejemplares similares

A Prospective Observational Study Comparing Long-Course Conventional Neoadjuvant Chemoradiotherapy with Short-Course Radiotherapy Followed by Consolidation Chemotherapy with Delayed Surgery in Locally Advanced Rectal Cancer
por: Thakur, Niketa, et al.
Publicado: (2020)

Breast cancer risk factor evaluation in a Western Himalayan state: A case–control study and comparison with the Western World
por: Thakur, Purnima, et al.
Publicado: (2017)

Knowledge of breast cancer risk factors and methods for its early detection among the primary health-care workers in Shimla, Himachal Pradesh
por: Fotedar, Vikas, et al.
Publicado: (2019)

Evaluation of Acute Toxicity and Early Clinical Outcome in Head and Neck Cancers Treated With Conventional Radiotherapy and Simultaneous Integrated Boost Arc Radiotherapy
por: Bahl, Amit, et al.
Publicado: (2017)

Correction: Evaluation of Acute Toxicity and Early Clinical Outcome in Head and Neck Cancers Treated With Conventional Radiotherapy and Simultaneous Integrated Boost Arc Radiotherapy
por: Bahl, Amit, et al.
Publicado: (2017)

DCE-MRI and parametric imaging in monitoring response to neoadjuvant chemotherapy in breast carcinoma: a preliminary report
por: Sharma, Anjna, et al.
Publicado: (2018)

Factors Impacting Quality of Life of Caregivers of Cancer Patients in the Sub-Himalayan Region: A Cross-Sectional Study
por: Singh, Kaalindi, et al.
Publicado: (2023)

Trimodality Therapy in which Concurrent Chemoradiation with Concomitant Boost in Muscle Invasive TCC Urinary Bladder Cancer
por: Mohammed, Ayatallah Ali Youssief, et al.
Publicado: (2023)

Methotrexate, an attractive agent for palliation in head and neck cancers
por: Sharma, Mukesh, et al.
Publicado: (2014)

Different fractionation regimes in palliative thoracic radiotherapy: Some facets
por: Sharma, Mukesh, et al.
Publicado: (2015)

Comparison of 3D Confromal Radiotherapy and Intensity Modulated Radiotherapy with or without Simultaneous Integrated Boost during Concurrent Chemoradiation for Locally Advanced Head and Neck Cancers
por: Spiotto, Michael T., et al.
Publicado: (2014)

Effects of Exercise Training during Concomitant Chemoradiation Therapy in Head-and-Neck Cancer Patients: A Systematic Review
por: D’souza, Macrina, et al.
Publicado: (2020)

Phase II Study of Cetuximab Plus Concomitant Boost Radiotherapy in Japanese Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck
por: Okano, Susumu, et al.
Publicado: (2013)

Normal Tissue Complications following Hypofractionated Chest Wall Radiotherapy in Breast Cancer Patients and Their Correlation with Patient, Tumor, and Treatment Characteristics
por: Khan, Mohsin, et al.
Publicado: (2017)

Long-term outcome and toxicity of hypofractionated stereotactic body radiotherapy as a boost treatment for head and neck cancer: the importance of boost volume assessment
por: Lee, Dong Soo, et al.
Publicado: (2012)

Prospective randomized trial to compare the outcome and tolerability of delivering the same total dose of radiation in 61/2 weeks versus 51/2 weeks time in head and neck cancers
por: Gupta, Manoj, et al.
Publicado: (2015)

When Palliative Treatment Achieves More Than Palliation: Instances of Long-term Survival after Palliative Radiotherapy
por: Rastogi, Madhup, et al.
Publicado: (2012)

A Study Comparing Acute Toxicities of Cetuximab and Cisplatin in Patients Undergoing Definitive Chemoradiation With Intensity-Modulated Radiotherapy for Locally Advanced Carcinoma Head and Neck
por: Venkateshulu, Shruthi, et al.
Publicado: (2021)

Assessing feasibility, compliance and toxicity of concomitant chemo‐radiotherapy in head and neck cancers in the Northern Territory: initial experience and challenges
por: Gupta, Ajay, et al.
Publicado: (2016)

Comparative study of concomitant chemoradiation versus concomitant chemoradiation followed by high-dose-rate intraluminal brachytherapy in locally advanced esophageal carcinoma: a single institutional study
por: Halder, Anirban, et al.
Publicado: (2018)

Comparison of Acute and Late Toxicity of Two Regimens of 3- and 5-Week Concomitant Boost Prone IMRT to Standard 6-Week Breast Radiotherapy
por: Raza, Shahzad, et al.
Publicado: (2012)

Clinical results of external beam radiotherapy alone with a concomitant boost program or with conventional fractionation for cervical cancer patients who did not receive intracavitary brachytherapy
por: Matsuura, Kanji, et al.
Publicado: (2012)

Comparison of iso-effective and cost-effective high-dose-rate brachytherapy treatment schedules in cervical cancer – regional cancer center experience
por: Thakur, Purnima, et al.
Publicado: (2019)

Primary Concurrent Chemoradiation in Head and Neck Cancers with Weekly Cisplatin Chemotherapy: Analysis of Compliance, Toxicity and Survival
por: Iqbal, Muhammad Shahid, et al.
Publicado: (2016)

Brachytherapy boost after chemoradiation in anal cancer: a systematic review
por: Frakulli, Rezarta, et al.
Publicado: (2018)

Concomitant Chemoradiation Therapy with Gold Nanoparticles and Platinum Drugs Co-Encapsulated in Liposomes
por: Charest, Gabriel, et al.
Publicado: (2020)

Comparison of long-term survival and toxicity of simultaneous integrated boost vs conventional fractionation with intensity-modulated radiotherapy for the treatment of nasopharyngeal carcinoma
por: Tao, Hengmin, et al.
Publicado: (2016)

A prospective comparative study between concurrent chemoradiation with brachytherapy boost with concurrent chemoradiation alone in locally advanced cancer esophagus
por: Tudu, Rajanigandha
Publicado: (2020)

Concomitant Radiotherapy and Chemotherapy for High-Risk Nonmelanoma Skin Carcinomas of the Head and Neck
por: Apisarnthanarax, Smith, et al.
Publicado: (2011)

A Comparison Between Sequential Conventional and Hypofractionated Boost Following Whole-Breast Radiotherapy: A Propensity Score-Matched Analysis
por: Rajan, Jewel, et al.
Publicado: (2023)

Randomized trial on acute toxicities of weekly vs three‐weekly cisplatin‐based chemoradiation in head and neck cancer
por: Ameri, Ahmad, et al.
Publicado: (2021)

Sarcopenia and Treatment Toxicity in Older Adults Undergoing Chemoradiation for Head and Neck Cancer: Identifying Factors to Predict Frailty
por: Morse, Ryan T., et al.
Publicado: (2022)

Effect of neoadjuvant chemoradiation and postoperative radiotherapy on expression of heat shock protein 70 (HSP70) in head and neck vessels
por: Tavassol, Frank, et al.
Publicado: (2011)

Factors predictive of parametrial boost in patients with cervical cancer treated with definitive chemoradiation
por: Jamora, Kurl E., et al.
Publicado: (2022)

ACT-10 TREATMENT FOR GLIOBLASTOMA RECURRED AFTER CONCOMITANT CHEMORADIATION THERAPY WITH TEMOZOLOMIDE AND THEIR PROGNOSIS
por: Mori, Kanji, et al.
Publicado: (2019)

Intensity-Modulated Radiotherapy with Concomitant Boost After Breast Conserving Surgery: A Phase I–II Trial
por: Macchia, Gabriella, et al.
Publicado: (2020)

Diffuse hepatic and splenic Tc-99m MDP tracer uptake in case of multiple myeloma
por: Sood, Ashwani, et al.
Publicado: (2010)

Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival
por: Morganti, Alessio G., et al.
Publicado: (2019)

Adjuvant concurrent chemoradiation using intensity-modulated radiotherapy and simultaneous integrated boost for resected high-risk adenocarcinoma of the distal esophagus and gastro-esophageal junction
por: Yaremko, Brian P, et al.
Publicado: (2013)

The predictive and prognostic value of low skeletal muscle mass for dose-limiting toxicity and survival in head and neck cancer patients receiving concomitant cetuximab and radiotherapy
por: Huiskamp, L. F. J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jauq7ejjfm2gn8u9ivosgssph0